Clinical Trials Directory

Trials / Unknown

UnknownNCT02368704

Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether Endoplasmic Reticulum (ER) stress pathway is activated in peripheral tissues (adipose tissue) in insulin resistant diabetic patients compared to healthy subjects normoglycemic matched for age and sex an to investigate whether ER stress pathway can be activated in response to insulin. Indeed, some preliminar on rates studies shows that ER stress pathway is activated by insulin in liver and adipose tissue showing that hyperinsulinemia might help trigger stress path ER. For this, we propose a case control study of type 2 diabetic patients vs control subjects in which markers of ER stress will be evaluated from abdominal subcutaneous adipose tissue obtained before and after euglycemic hyperinsulinemic. We chose to consider adipose tissue subcutaneous rather than visceral adipose tissue for obvious reasons of lesser invasiveness.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2012-11-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2015-02-23
Last updated
2016-04-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02368704. Inclusion in this directory is not an endorsement.